Abstract
<p><em>Diabetes mellitus (DM) is the condition of metabolism affected by chronic hyperglycemia (the increase of glucose levels in the blood) caused by insulin secretion defect. One of the non-pharmacological therapies used to decrease the type 2 DM is cognitive behavioral therapy. The objective of the research was to identify the effect of Cognitive Behavior Therapy (CBT) on self management and self-care behaviors of type 2 DM patients. The research used a quasi-experimental method with a two</em><em>-</em><em>group pretest-posttest design. The samples were 70 respondents with 35 of them were in the intervention group and the other 35 were in the control group, taken by using a consecutive sampling technique. The data were gathered using the Diabetes Self-Management Questionnaires (DSMQ) and the Summary of Diabetes Self-Care Activities (SDSCA) questionnaires. The gathered data were analyzed by using paired t-test, and independent t-test. The results of the study showed that there were significantly differences of mean scores of self management and self care behaviors between intervention and control groups </em>(<em>t</em>=13.24; <em>p</em>=0.00) and<em>(t=14.63,</em><em></em><em>p=0.00), respectively. It is recommended that cognitive behavior therapy can be used as one of the non-pharmacological therapies</em><em></em><em>to change self-care behaviors in type 2 DM patients.</em></p>
Highlights
IntroductionDiabetes mellitus (DM) is a metabolic condition characterized by the occurrence of chronic hyperglycemia (the increase of blood sugar levels) caused by defective insulin secretion
Diabetes mellitus (DM) is a metabolic condition characterized by the occurrence of chronic hyperglycemia caused by defective insulin secretion
A survey by Basic Health Research showed that the number of type 2 DM patients in North Sumatra was at 1.4% of the population (Milita, Handayani, & Setiaji, 2021)
Summary
Diabetes mellitus (DM) is a metabolic condition characterized by the occurrence of chronic hyperglycemia (the increase of blood sugar levels) caused by defective insulin secretion. The data from (Atlas, 2015) estimates that the incidence of type 2 DM is higher than the incidence of type 1 DM. During 2015-2018, the incidence of type 2 DM reached 415 million patients from several countries, including the United States of America with a prevalence of around 10-15%, Caucasia 4-6%, and Africa 2-4%. By 2040, the incidence of type 2 DM will increase to 642 million people in the world. A survey by Basic Health Research showed that the number of type 2 DM patients in North Sumatra was at 1.4% of the population (Milita, Handayani, & Setiaji, 2021). The highest incidences were in Deli Serdang Regency (1.9%), Medan
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
